Cart
sales@molnova.com
3,5-Di-tert-butylphenol
CAS No. 1138-52-9
3,5-Di-tert-butylphenol( —— )
Catalog No. M28085 CAS No. 1138-52-9
3,5-Di-tert-butylphenol induces accumulation of reactive oxygen species. 3,5-Di-tert-butylphenol exhibits anti-biofilm and antifungal activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3,5-Di-tert-butylphenol
-
NoteResearch use only, not for human use.
-
Brief Description3,5-Di-tert-butylphenol induces accumulation of reactive oxygen species. 3,5-Di-tert-butylphenol exhibits anti-biofilm and antifungal activities.
-
Description3,5-Di-tert-butylphenol induces accumulation of reactive oxygen species. 3,5-Di-tert-butylphenol exhibits anti-biofilm and antifungal activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetROS
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1138-52-9
-
Formula Weight206.329
-
Molecular FormulaC14H22O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (484.68 mM)
-
SMILESCC(C)(C)c1cc(O)cc(c1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yin H, et al. Electrochemical immunosensor for N6-methyladenosine detection in human cell lines based on biotin-streptavidin system and silver-SiO2 signal amplification. Biosens Bioelectron. 2017 Apr 15;90:494-500.
molnova catalog
related products
-
Tempol
Tempol is a superoxide scavenger that displays neuroprotective, anti-inflammatory and analgesic effects.
-
SFI003
SFI003 is a novel SRSF3 inhibitor that exerts anticancer activity against colorectal cancer by modulating the SRSF3 / DHCR24 / ROS axis and driving apoptosis in CRC cells through the SRSF3 / DHCR24 / reactive oxygen species (ROS) axis.
-
Medicarpin
Medicarpin a legume phytoalexin acts as an estrogen receptor (ER) agonist can stimulate osteoblast differentiation likely via ERα2 promote achievement of peak bone mass and is devoid of uterine estrogenicity; in addition given its excellent oral bioavailability it can be potential osteogenic agent.
